More than 300 horses and ponies have been tested for pituitary pars intermedia dysfunction (PPID) during the first seven weeks of Boehringer Ingelheim Vetmedica’s successful ‘Talk About Laminitis’ initiative.

More than 300 horses and ponies have been tested for pituitary pars intermedia dysfunction (PPID) during the first seven weeks of Boehringer Ingelheim Vetmedica’s successful ‘Talk About Laminitis’ initiative.

The scheme, which offers free adrenocorticotropic hormone (ACTH) tests and runs to the end of November, has already led to a reappraisal of the ages of horses tested for PPID.

Laminitic hoofProf Andy Durham from the Liphook Equine Hospital said: “For years we have known that horses and ponies with PPID are prone to laminitis, but recent evidence suggests that actually the majority of laminitis cases are caused by an underlying endocrine disease.

“The last 24 months have been an absolute revolution in the number of laminitis cases tested for PPID, which is excellent medicine because if you don’t test, you may be at risk of missing the diagnosis.”

Tests performed this spring showed that PPID may affect up to one third of laminitic horses and ponies between the age of 10 and 15.

Boehringer’s equine business manager Liz Barrett added: “We are encouraging veterinary surgeons to submit tests from all cases of laminitis they see in horses from the age of 10. During the autumn initiative, more than half of the 10 to 15 year old horses tested have been positive for PPID.”

View your activity >

Leave a Reply

Be the First to Comment!

Notify of
avatar

wpDiscuz